• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Outcomes of pharmacogenetics-guided dosing of warfarin: a systematic review and meta-analysis.

作者信息

Tang Qinghui, Zou Houjuan, Guo Caihong, Liu Zhengxiang

机构信息

Department of Cardiology of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.

Department of Cardiology of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.

出版信息

Int J Cardiol. 2014 Aug 20;175(3):587-91. doi: 10.1016/j.ijcard.2014.06.031. Epub 2014 Jun 28.

DOI:10.1016/j.ijcard.2014.06.031
PMID:25005340
Abstract
摘要

相似文献

1
Outcomes of pharmacogenetics-guided dosing of warfarin: a systematic review and meta-analysis.华法林药物基因组学指导剂量给药的结果：一项系统评价和荟萃分析。
Int J Cardiol. 2014 Aug 20;175(3):587-91. doi: 10.1016/j.ijcard.2014.06.031. Epub 2014 Jun 28.
2
Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.抗凝治疗前进行基因检测？华法林药物基因组剂量学的系统评价。
J Gen Intern Med. 2009 May;24(5):656-64. doi: 10.1007/s11606-009-0949-1. Epub 2009 Mar 21.
3
Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.基因检测对维生素 K 拮抗剂初始剂量出血并发症的影响：系统评价和荟萃分析。
J Thromb Haemost. 2014 Sep;12(9):1480-7. doi: 10.1111/jth.12647. Epub 2014 Jul 24.
4
Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.华法林基因导向药物遗传学给药的疗效和安全性的荟萃分析。
Int J Cardiol. 2014 Dec 15;177(2):654-7. doi: 10.1016/j.ijcard.2014.09.174. Epub 2014 Oct 7.
5
Pharmacogenetics-based warfarin dosing algorithm decreases time to stable anticoagulation and the risk of major hemorrhage: an updated meta-analysis of randomized controlled trials.基于药物遗传学的华法林给药算法可缩短达到稳定抗凝的时间并降低大出血风险：一项随机对照试验的更新荟萃分析。
J Cardiovasc Pharmacol. 2015 Apr;65(4):364-70. doi: 10.1097/FJC.0000000000000204.
6
Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.基于药物遗传学的华法林剂量与传统剂量对比：随机对照试验的荟萃分析
PLoS One. 2015 Dec 16;10(12):e0144511. doi: 10.1371/journal.pone.0144511. eCollection 2015.
7
Efficacy and Safety of Genotype-Guided Warfarin Dosing in the Chinese Population: A Meta-analysis of Randomized Controlled Trials.基因型指导的华法林剂量在中国人群中的疗效和安全性：一项随机对照试验的荟萃分析。
J Cardiovasc Pharmacol. 2019 Mar;73(3):127-135. doi: 10.1097/FJC.0000000000000656.
8
Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.香豆素类抗凝剂的基因型指导给药：随机对照试验的荟萃分析
J Cardiovasc Pharmacol Ther. 2015 Jul;20(4):387-94. doi: 10.1177/1074248414565666. Epub 2015 Jan 8.
9
Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials.基因型指导下的药物处方：随机对照试验的系统评价和荟萃分析
Br J Clin Pharmacol. 2015 Oct;80(4):868-77. doi: 10.1111/bcp.12475. Epub 2015 Jul 22.
10
Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?华法林药物基因组学试验：药物基因组学指导剂量是否有未来？
Pharmacogenomics. 2014 Apr;15(6):719-22. doi: 10.2217/pgs.14.18.

引用本文的文献

1
Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis.实施药物基因组学临床决策支持系统用于卫生系统：成本效用分析。
Pharmacogenomics J. 2022 May;22(3):188-197. doi: 10.1038/s41397-022-00275-7. Epub 2022 Apr 1.
2
Variants in , and Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease.心血管疾病患者中与对华法林敏感性和反应相关的、和基因的变异
Int J Gen Med. 2021 Mar 25;14:1093-1100. doi: 10.2147/IJGM.S298597. eCollection 2021.
3
Warfarin dosing algorithms: A systematic review.
华法林剂量算法：系统评价。
Br J Clin Pharmacol. 2021 Apr;87(4):1717-1729. doi: 10.1111/bcp.14608. Epub 2020 Nov 18.
4
Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine.心血管疾病治疗中的药物遗传学及其在临床常规中的实施现状。
Genes (Basel). 2019 Apr 1;10(4):261. doi: 10.3390/genes10040261.
5
Precision dosing of warfarin: open questions and strategies.华法林精准剂量：未解决的问题与策略。
Pharmacogenomics J. 2019 Jun;19(3):219-229. doi: 10.1038/s41397-019-0083-3. Epub 2019 Feb 12.
6
Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.基于基因型的华法林剂量调整与传统剂量策略的比较：一项随机对照试验的系统评价和荟萃分析。
Br J Clin Pharmacol. 2018 Sep;84(9):1868-1882. doi: 10.1111/bcp.13621. Epub 2018 Jun 21.
7
VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.VKORC1和CYP2C9基因多态性与抗凝患者病例对照队列中的不良事件相关。
Medicine (Baltimore). 2016 Dec;95(52):e5451. doi: 10.1097/MD.0000000000005451.
8
Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.基于药物遗传学的华法林剂量与传统剂量对比：随机对照试验的荟萃分析
PLoS One. 2015 Dec 16;10(12):e0144511. doi: 10.1371/journal.pone.0144511. eCollection 2015.
9
Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.新一代基因组技术对理解药物不良反应的影响。
Clin Pharmacokinet. 2016 Apr;55(4):419-36. doi: 10.1007/s40262-015-0324-9.
10
Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.与标准疗法相比，基因型指导的华法林起始剂量算法的临床效用有限：一项对11项随机对照试验的荟萃分析和试验序贯分析。
Pharmacogenomics J. 2015 Dec;15(6):496-504. doi: 10.1038/tpj.2015.16. Epub 2015 Apr 14.